Myocardial infarction: urgent angioplasty did not improve prognosis.
|
|
|
Clinical bottom line (level 1b)
-
In patients with first myocardial infarction, a strategy of urgent angiography after thrombolysis did not reduce death or reinfarction at 12 months
(NNH =
40
at 12
months)
.
|
|
SWIFT (Should We Intervene Following Thrombolysis?) Trial Study Group
:
British Medical Journal
1991;
302:
555-560
|
Expires
November 2003
|
The study
Unblinded ?concealed randomised
trial
with
intention-to-treat
Setting: 21 district hospitals and regional cardiac centres in UK and Ireland
800 patients
(aged
mean 55y (SD 9y),
82%
male)
first myocardial infarction thrombolysed within 3.5 hours of onset of symptoms (diagnosed by symptoms & ST elevation)
Excluded if
- >69 years old
- shock (systolic BP <80 mmHg) or hypertension (BP >200/120 mmHg)
- bleeding diathesis or menstruation
- active peptic ulceration <1 year
- surgery or trauma <3 months
- streptokinase or anistreplase <6 months
- diabetic proliferative retinopathy
- life expectancy <2 years
Note:
- 68% of the experimental group received a further intervention; angioplasty or CABG.
Control Group: (n = 403, 369 analysed):
angiography at standard clinical indication
Experimental Group: (n = 397, 374 analysed):
urgent angiography within 48h of infarct, with angioplasty or bypass surgery as indicated
Patients also received anistreplase and heparin; and oral beta-adrenoceptor antagonists if there were no contraindications.
93% followed for
12
months
The evidence
| Outcome |
Time to outcome |
CER | EER | RRR (95% CI) | ARR (95% CI) | NNT (95% CI) |
| in hospital mortality
|
.
unknown |
13 (3.23%) |
11 (2.77%) |
14% (-89% to
61%) |
0.46% (-1.91% to
2.82%) |
220
(NNT =
52
to infinity;
NNH = 35 to infinity)
|
| death or reinfarction
|
12
months |
67 (16.6%) |
76 (19.1%) |
-15% (-55% to
15%) |
-2.52% (-7.83% to
2.79%) |
-40
(NNT =
13
to infinity;
NNH = 36 to infinity)
|
- Mortality in the registered but non-randomised group was markedly higher; 13% vs 3% (in-hospital).
Comments
- This study is too small to rule out an important clinical difference in mortality alone.
- The combined clinical endpoint of death or reinfarction is not improved, and may be worsened, by a strategy of urgent angiography.
Citation
-
SWIFT (Should We Intervene Following Thrombolysis?) Trial Study Group
,
:
SWIFT trial of delayed elective intervention v conservative treatment after thrombolysis with anistreplase in acute myocardial infarction.
British Medical Journal
1991;
302:
555-560
Contributor: Bob Phillips and Clare Wotton,
November 1999
Reviewer:
Clinical Question.
| Patient |
patients with first myocardial infarction |
| Intervention or Exposure |
urgent angiography with consideration of surgery/angioplasty |
| Comparison |
elective angiography as per usual clinical course |
| Outcome |
mortality; reinfarction |
|
|